The Multi-faceted AT2 Receptor
David Kem, MD, George Lynn Research Professor, Regents’ Professor of Medicine, Department of Medicine/Endocrinology and the Heart Rhythm Institute
Upon completion of this activity, participants will be able to: Review the diversity of actions of the AT2R. To demonstrate the potential therapeutic impact of our newly invented AT2R autoantibody agonist.
For more information contact:
Department of Medicine/Endocrinology and Diabetes